[ad_1]
Moderna has decided to present EU authorization for its coronavirus vaccine for us. According to today’s article on ForexLive, “Moderna reiterates that its vaccine is 94.1% effective in primary analysis
– The vaccine was 94.1% effective in the analysis of the phase 3 study, after 196 cases of the virus
– The vaccine was 100% effective against severe virus cases being tested
Another Monday, another dose of optimism about vaccines to get on the market “.
Moderna to ask the FDA to authorize the vaccine. According to today’s article in the Wall Street Journal, “Moderna will ask the United States”
According to today’s Bloomberg Quint article, “Moderna Plans to Seek US, EU Clearance for Covid Vaccine”.
Moderna will present EUA for coronavirus vaccine candidate, which predicted 94.1% efficacy. According to today’s article on MarketWatch, “Moderna Inc”
According to today’s article on MarketWatch, “Moderna shares rise 11% on application for emergency use authorization for vaccine.”
Stocks that make the biggest moves before the market: Moderna, IHS markit, slack and more. According to today’s article on CNBC, “Some of the titles posting the biggest moves before the bell include Moderna, IHS Markit, Slack, and others ..”
Stocks that make the biggest moves before the market: Moderna, IHS markit, slack and more. According to today’s article on CNBC, “Some of the titles posting the biggest moves before the bell include Moderna, IHS Markit, Slack, and others ..”
Stocks that make the biggest moves at noon: Moderna, IHS markit, nikola, Carnival and more. According to today’s article on CNBC, “Moderna shares the report on strong data.”
Modern stock was up a staggering 17.3% to $ 149.00 at 3:08 PM EST on Monday after two consecutive earnings sessions. The Nasdaq stock market is sliding 0.16% to $ 12,185.90, after four consecutive sessions of gains, on what looks like a somewhat negative trending trading session today.
Moderna’s last close was $ 127.03, 1.34% below the 52-week high of $ 151.00.
Moderna sales growth is 1425.2% for the current quarter and 9666.5% for the next. The company’s growth estimates for the current quarter are negative by 48.6% and positive by 437.1% for the next.
Growth in quarterly turnover on an annual basis grew by 826.4%, reaching 246.7 million in the final twelve months.
Modern stock is valued at $ 149.00 at 3:08 PM EST, below the 52-week high of $ 151.00 and much higher than the 52-week low of $ 17.68.
Moderna is well above its 50-day moving average of $ 80.78 and well above its 200-day moving average of $ 70.99.
Source link
